Viewing Study NCT02533505


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-05-17 @ 11:41 AM
Study NCT ID: NCT02533505
Status: COMPLETED
Last Update Posted: 2018-07-30
First Post: 2015-07-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase IV O2 Consumption Study in COPD Patients.
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease (COPD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Respiratory View
None O2 Consumption View
None COPD View